newwin
Luciann Nguyen
Settings
← Accounts
academic

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

44
Account opportunity
Not established
Relationship
1
Active signals
1
Trials as sponsor

Why this account matters

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

New trial — Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors

New trialNCT07396090
44/100
Opportunity
Commercial fit11/25
Clinical timing11/20
Biomarker need5/20
Relationship2/10
Signal strength9/10
Account value5/10
Urgency1/5

New not applicable trial NCT07396090 posted by Cancer Institute and Hospital, Chinese Academy of Medical Sciences: "Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors". New trial on a not applicable not yet recruiting study is a moment when external vendors are commonly selected or expanded (spec §70).

Why nowClinicalTrials.gov record updated 211 days ago.

ConfidenceHigh · 87%clinical development · translational medicine · clinical operations
Draft outreachReview

NextHold. Score is below the tenant threshold (55). Keep on the watchlist for follow-on signals.

Trials

TrialPhaseTesting language
NCT07396090
Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors
not applicable
—